This trial aims to see if incentives can help teens with diabetes use insulin better, using semi-automated tech.
- Type 1 Diabetes
3 Primary · 0 Secondary · Reporting Duration: change in week 0 outcome at week 13
Awards & Highlights
2 Treatment Groups
Standard Care Control
1 of 2
1 of 2
150 Total Participants · 2 Treatment Groups
Primary Treatment: Coin2Dose · No Placebo Group · N/A
Who is running the clinical trial?
Age 11 - 17 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does this research endeavor allow participants aged 18 and over?
"The criteria for being a part of this clinical trial states that the participant must be aged between 11 and 17." - Anonymous Online Contributor
Is it possible to register for this study at the current time?
"This clinical trial is still accepting participants. It was first listed on the 1st of January 2023 and last amended on 28th February 2023 per information provided by clinicaltrials.gov." - Anonymous Online Contributor
Am I eligible to participate in this scientific investigation?
"This trial is on the search for 150 juvenile individuals with type 1 diabetes, aged between 11 and 17 years. To be eligible to participate, adolescents must have a doctor-verified diagnosis of T1D lasting at least 6 months; they should use insulin pumps to manage their condition; and they need to demonstrate suboptimal daily BOLUS scores (a mean score lower than 2.5)." - Anonymous Online Contributor
How many participants are currently involved in this research endeavor?
"Affirmative. The info hosted on clinicaltrials.gov reveals that this research, which was initially advertised on January 1st 2023, is still actively recruiting participants. 150 people are required to be enrolled from 2 medical centres." - Anonymous Online Contributor